POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction

Whole genome/exome sequencing data for tumors are now abundant, and many tumor antigens, especially mutant antigens (neoantigens), have been identified for cancer immunotherapy. However, only a small fraction of the peptides from these antigens induce cytotoxic T cell responses. Therefore, efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Qingqing, Wu, Yahong, Sui, Xinghua, Meng, Jingjie, Wang, Tingting, Lin, Yan, Wang, Zhiwei, Zhou, Xiuman, Qi, Yuanming, Du, Jiangfeng, Gao, Yanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579403/
https://www.ncbi.nlm.nih.gov/pubmed/33133063
http://dx.doi.org/10.3389/fimmu.2020.02193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579403/
https://www.ncbi.nlm.nih.gov/pubmed/33133063
http://dx.doi.org/10.3389/fimmu.2020.02193

Ejemplares similares